Sunny Pharmtech Inc. (6676.TWO)

TWD 21.85

(-0.46%)

Annual Income Statements

(In TWD)
Breakdown 2023 2022 2021 2020 2019
Revenue 428.82 Million 359.58 Million 240.99 Million 419.94 Million 234.48 Million
Cost of Revenue 143.3 Million 152.87 Million 125.24 Million 195.87 Million 139.22 Million
Gross Profit 285.52 Million 206.7 Million 115.74 Million 224.06 Million 95.25 Million
Operating Expenses 357.62 Million 394.32 Million 291.75 Million 298.41 Million 314.27 Million
Selling, General and Administrative Expenses 148.75 Million 138.45 Million 120.38 Million 116.36 Million 103.64 Million
Research and Development Expenses 208.86 Million 255.87 Million 171.36 Million 182.04 Million 205.64 Million
Other Expenses - 20.58 Million 6.47 Million -22.1 Million -
Cost and Expenses 500.92 Million 547.2 Million 417 Million 494.28 Million 453.5 Million
Operating Income -72.09 Million -165.65 Million -169.16 Million -94.96 Million -214.04 Million
Interest Expense 11.24 Million 4.58 Million 5.62 Million 6.79 Million 8.28 Million
Income Tax Expense - - - - -
Earnings before Tax -63.32 Million -170.24 Million -174.79 Million -101.76 Million -226.29 Million
Net Income -63.32 Million -170.24 Million -174.79 Million -101.76 Million -226.29 Million
Earnings Per Share Basic -0.44 -1.23 -1.28 -0.77 -1.76
Earnings Per Share Diluted -0.44 -1.23 -1.28 -0.77 -1.76
Weighted Average Shares Outstanding 142.73 Million 138.52 Million 136.49 Million 131.49 Million 128.67 Million
Weighted Average Shares Outstanding (Diluted) 142.73 Million 138.52 Million 136.49 Million 131.49 Million 128.67 Million
Gross Margin 0.67 0.57 0.48 0.53 0.41
EBIT Margin 0.16 -0.15 -0.27 0.03 -0.52
Profit Margin -0.15 -0.47 -0.73 -0.24 -0.97
EBITDA 69.14 Million -53.95 Million -64.31 Million 10.65 Million -119.65 Million
Earnings Before Tax Margin -0.17 -0.46 -0.70 -0.23 -0.91

Income Statement Charts